je.st
news
Orexigen: Contrave Sales Set New Record- Still Not Enough To Satisfy The Street
2015-09-15 03:32:09| Biotech - Topix.net
Orerxigen understand first hand what it is like to be the leader in a sector and still get the stock beat up. The main reason for that is that despite outpacing the competition in the branded anti-obesity sector, sales are much lower than what is needed to deliver the level of revenue that will impress the street.
Tags: to
the
set
sales
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||